Elanco moves to dismiss 'duplicative' Tevra US antitrust case over flea, tick treatments
MLex Summary: Elanco Animal Health moved to dismiss a "duplicative" complaint by Tevra Brands over its allegations that Elanco monopolized the US market for imidacloprid topics for dogs and cats, telling...To view the full article, register now.
Already a subscriber? Click here to view full article